Oncology Information System Market Size, Share, Growth, and Industry Analysis, By Type (Patient Information Systems,Treatment Planning Systems), By Application (Hospitals,Governmental Institutions,Research Centers), Regional Insights and Forecast to 2035

Oncology Information System Market Overview

The global Oncology Information System Market size is projected to grow from USD 2692.92 million in 2026 to USD 2808.72 million in 2027, reaching USD 3933.58 million by 2035, expanding at a CAGR of 4.3% during the forecast period.

The Oncology Information System (OIS) Market comprises software and service solutions that manage cancer patient workflows, treatment planning, data management, and clinical decision support across medical, radiation, and surgical oncology disciplines. In 2022, the OIS market was estimated around USD 3.1 billion, with the software segment holding approximately 83.2 % share of deployments. In 2024, the global OIS market was re-estimated at USD 3.3 billion, and North America’s share was recorded at 42.3 % of the total market. Integration of artificial intelligence, imaging, and interoperability modules is central in current Oncology Information System Market Trends.

In the United States, the Oncology Information System Market is a mature segment, with the U.S. accounting for roughly 30.6 % of the global market in 2024. The U.S. oncology information systems market was valued at about USD 900.3 million in 2024, deploying in hundreds of major cancer centers and academic medical centers. In 2023, the U.S. OIS market was estimated at USD 840.25 million, with medical oncology accounting for 60.84 % of U.S. share and software comprising 73.25 % of U.S. applications. The U.S. dominance is supported by advanced healthcare IT infrastructure, high cancer incidence (over 2 million new cases projected in 2024), and integration into national oncology care protocols.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:96 million new global cancer cases in 2022 (percentage-wise basis of burden)
• Major Market Restraint: 45 % of hospitals cite high implementation complexity as barrier
• Emerging Trends:2 % software share in OIS deployments
• Regional Leadership: North America held 42.3 % share in 2022 in Oncology Information System Market Share
• Competitive Landscape: Top two firms control about 25 % combined share in Oncology Information System Market Share
• Market Segmentation: Medical oncology accounts for ~61.8 % share in 2024
• Recent Development: 58 % of new European OIS deployments included compliance modules

Oncology Information System Market Latest Trends

In recent years, Oncology Information System Market Trends show accelerating adoption of integrated digital platforms combining imaging, treatment planning, and analytics. In 2022, software accounted for 83.2 % of total OIS implementations globally, while professional services made up the remainder. A major trend is the shift from standalone radiation planning modules to unified oncology suites spanning medical, surgical, and radiation workflows; in 2024, ~61.8 % of deployments centered on medical oncology applications. Interoperability is another core trend: more than 45 % of new installations now support HL7 FHIR interfaces for better EHR integration across departmental boundaries.

Oncology Information System Market Dynamics

DRIVER

"Rising global cancer burden and need for improved care efficiency"

Cancer incidence is climbing worldwide: in 2022, approximately 19.96 million new cancer cases were reported, causing about 9.73 million deaths globally. This mounting burden drives demand for digital oncology management systems to support scheduling, treatment planning, outcome tracking, and data sharing. In advanced healthcare settings, more than 60 % of large cancer centers now mandate an OIS system to link multidisciplinary teams—surgical, radiation, medical oncology.

RESTRAINT

"Implementation complexity, high capital and IT burden"

Despite the clear need, many institutions hesitate. Implementation of OIS platforms often involves integration with legacy systems, imaging archives, treatment planning modules, and electronic health records. In surveys, 45 % of hospitals cite complexity and disruption as a barrier. Smaller cancer centers in low-income regions may lack the IT staff, with ~38 % reporting insufficient technical expertise. Data migration from paper or older systems leads to workflow disruption: 27 % of institutions report delays over 6 months in full deployment.

OPPORTUNITY

"Growth in emerging markets, precision oncology, and cloud deployment"

Emerging economies—particularly in Asia Pacific, Latin America, and Middle East & Africa—offer strong opportunity. In 2023, Asia-Pacific accounted for ~19 % of global OIS demand, with India, China, and Southeast Asian nations rapidly investing in oncology infrastructure. Many new cancer centers include OIS in initial capital budgets. Precision oncology is another growth vector: OIS platforms are incorporating genomics, biomarker, and AI modules; as of 2024, ~28 % of OIS vendors offered integrated genomic analytics.

CHALLENGE

"Data security, regulatory compliance, and vendor fragmentation"

Deploying OIS systems entails high expectations for data security and compliance. Oncology data is highly sensitive, and ~31 % of institutions cite risk of breach or non-compliance as a critical concern. Ensuring HIPAA, GDPR, and country-specific data privacy rules increases overhead and complexity. Additionally, securing audit logs, identity management, and encryption for large imaging and genomic files is nontrivial. Fragmentation in vendor offerings presents another challenge: many institutions use separate systems for radiation planning, EHR, lab systems, and imaging; ~42 % of oncology departments suffer interoperability gaps.

Oncology Information System Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

The Oncology Information System Market segmentation is based on Type (Patient Information Systems and Treatment Planning Systems) and Application / End-user (Hospitals, Governmental Institutions, Research Centers).

BY TYPE

Patient Information Systems: Patient Information Systems in oncology manage patient demographics, scheduling, clinical workflows, oncology care pathways, safety checks, and outcome documentation. They account for a significant portion of OIS deployments—estimated at 40 % of total installations. Many newer OIS platforms offer unified modules that include patient information alongside treatment modules; in 2023, 38 % of newly installed OIS suites used integrated patient module stacks.

The Patient Information Systems segment is estimated at USD 1,462.6 million in 2025, accounting for 56.6% of total market share, and is projected to grow at a CAGR of 4.4% due to the rising use of integrated electronic patient record solutions and hospital digitalization initiatives.

Top 5 Major Dominant Countries in the Patient Information Systems Segment

• United States: Market size USD 534.5 million, share 36.5%, CAGR 4.5%, driven by advanced healthcare IT infrastructure and government support for digital oncology systems.
• Germany: Market size USD 152.7 million, share 10.4%, CAGR 4.3%, supported by EHR integration and data-driven oncology care models.
• China: Market size USD 137.1 million, share 9.4%, CAGR 4.5%, driven by increasing investments in hospital IT systems and oncology informatics.
• Japan: Market size USD 121.4 million, share 8.3%, CAGR 4.4%, due to strong adoption of patient-centric oncology platforms.
• India: Market size USD 103.6 million, share 7.1%, CAGR 4.6%, fueled by rapid digitization in oncology hospitals and healthcare modernization programs.

Treatment Planning Systems: Treatment Planning Systems handle dose calculations, beam arrangement, multi-modality image fusion, adaptive planning, and radiotherapy control. These systems are critical in radiation oncology. The treatment planning type accounts for ~60 % of the OIS software value proposition due to complexity. In radiation oncology segments, ~100 % of OIS installations include planning modules; often multiple vendors (e.g. Varian, Elekta, RaySearch) supply planning engines.

The Treatment Planning Systems segment is projected at USD 1,119.3 million in 2025, representing 43.4% of the total market, and is anticipated to register a CAGR of 4.2%, driven by AI-assisted planning tools and precision radiotherapy advancements.

Top 5 Major Dominant Countries in the Treatment Planning Systems Segment

• United States: Market size USD 418.2 million, share 37.3%, CAGR 4.3%, driven by high adoption of radiotherapy and proton therapy systems.
• China: Market size USD 146.8 million, share 13.1%, CAGR 4.4%, supported by rapid expansion of radiation oncology centers.
• Germany: Market size USD 118.5 million, share 10.6%, CAGR 4.2%, led by AI-based treatment planning technologies.
• Japan: Market size USD 105.9 million, share 9.5%, CAGR 4.3%, fueled by increasing precision oncology initiatives.
• France: Market size USD 93.2 million, share 8.3%, CAGR 4.1%, supported by integration of adaptive treatment solutions in cancer centers.

BY APPLICATION

Hospitals: Hospitals and cancer centers are the largest adopters of OIS. According to historical data, hospitals and oncology clinics dominated the OIS market in 2020 and remain principal users. In 2023, hospitals represented ~65 % of OIS end-user installations. Large academic medical centers often host 500+ oncology patients per year and deploy full OIS suites including patient modules, planning systems, analytics, and compliance.

The Hospitals segment is valued at USD 1,856.1 million in 2025, capturing 71.9% market share, and is projected to grow at a CAGR of 4.4%, driven by the need for centralized patient data and integrated oncology workflows.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: Market size USD 684.3 million, share 36.9%, CAGR 4.4%, driven by strong hospital IT infrastructure and adoption of oncology software systems.
• China: Market size USD 256.9 million, share 13.8%, CAGR 4.5%, supported by public hospital modernization initiatives.
• Germany: Market size USD 185.7 million, share 10.0%, CAGR 4.3%, driven by data integration in oncology departments.
• Japan: Market size USD 164.4 million, share 8.9%, CAGR 4.4%, fueled by smart hospital initiatives in cancer care.
• India: Market size USD 147.5 million, share 7.9%, CAGR 4.5%, supported by expansion of specialized oncology hospitals.

Governmental Institutions: Governmental institutions and public cancer centers, especially in Europe and Asia, adopt OIS to streamline national oncology care pathways. In EU countries, ~25 % of cancer centers in major nations have mandated OIS deployment via government funding. In India and China, national cancer control programs subsidize OIS adoption in ~30 % of new government hospitals.

The Governmental Institutions segment is estimated at USD 426.3 million in 2025, accounting for 16.5% share, and is projected to expand at a CAGR of 4.2%, driven by national cancer registry and data management programs.

Top 5 Major Dominant Countries in the Governmental Institutions Application

• United States: Market size USD 156.5 million, share 36.7%, CAGR 4.3%, supported by federal cancer surveillance and public health data systems.
• Germany: Market size USD 53.8 million, share 12.6%, CAGR 4.1%, driven by national cancer database integration.
• China: Market size USD 47.6 million, share 11.2%, CAGR 4.4%, fueled by government-led oncology information infrastructure.
• United Kingdom: Market size USD 39.1 million, share 9.2%, CAGR 4.2%, supported by NHS digital oncology initiatives.
• France: Market size USD 35.4 million, share 8.3%, CAGR 4.1%, driven by national health data interoperability programs.

Research Centers: Research centers, cancer institutes, and academic trial centers use OIS platforms to aggregate clinical, imaging, genomic, and outcomes data for studies. These research centers account for ~10 % of OIS deployments. They demand integration of clinical trial modules, de-identified data, and analytics tools.

The Research Centers segment is forecasted at USD 299.5 million in 2025, representing 11.6% of total share, and is projected to register a CAGR of 4.3%, driven by data analytics in oncology R&D.

Top 5 Major Dominant Countries in the Research Centers Application

• United States: Market size USD 109.4 million, share 36.5%, CAGR 4.4%, driven by investments in cancer research analytics and AI-based modeling.
• Germany: Market size USD 42.8 million, share 14.3%, CAGR 4.3%, supported by clinical data integration platforms.
• China: Market size USD 38.2 million, share 12.7%, CAGR 4.5%, driven by genomic oncology data initiatives.
• Japan: Market size USD 33.9 million, share 11.3%, CAGR 4.2%, focusing on AI-assisted oncology R&D.
• France: Market size USD 29.5 million, share 9.8%, CAGR 4.1%, supported by collaboration among cancer research institutes.

Oncology Information System Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

The regional performance in the Oncology Information System Market reveals North America as the leader, followed by Europe, Asia-Pacific, and Middle East & Africa. North America commands over 42 % share, thanks to advanced healthcare IT and high cancer prevalence. Europe maintains a strong presence driven by public healthcare systems and regulation. Asia-Pacific is expanding rapidly with rising cancer incidence and improving infrastructure. Middle East & Africa sees nascent OIS adoption in Gulf and South African cancer centers. Below breakdowns:

NORTH AMERICA

In 2022, North America accounted for 42.3 % of OIS Market Share. In 2024, its share in global oncology information systems rose to ~39.9 %, reflecting about USD 1.2 billion of deployments attributed to the region. The U.S. oncology information systems market contributed USD 900.3 million and made up 30.6 % of global market in 2024. Canadian oncology centers also adopt OIS modules.

The North American Oncology Information System market is valued at USD 1,132.9 million in 2025, capturing a 43.9% share, and is projected to grow at a CAGR of 4.3%, driven by advanced healthcare IT adoption and oncology data management.

North America - Major Dominant Countries in the “Oncology Information System Market”

• United States: Market size USD 903.5 million, share 79.7%, CAGR 4.4%, supported by widespread OIS adoption across hospitals and cancer centers.
• Canada: Market size USD 149.3 million, share 13.2%, CAGR 4.2%, driven by national e-health projects.
• Mexico: Market size USD 80.1 million, share 7.1%, CAGR 4.1%, supported by hospital IT modernization.
• Cuba: Market size USD 32.7 million, share 2.9%, CAGR 4.0%, led by cancer control programs.
• Dominican Republic: Market size USD 27.3 million, share 2.4%, CAGR 4.0%, supported by digital oncology initiatives.

EUROPE

Europe holds around 22–25 % of the global Oncology Information System Market share. Many European countries mandate cancer registry linkage, making OIS adoption more standardized. In 2023, ~58 % of new European OIS deployments included regulatory and compliance modules for national cancer reporting. The UK, Germany, France, Netherlands, and Norway are key adopters; in the U.K., ~45 cancer centers use unified OIS platforms across multiple sites.

The European market is valued at USD 782.7 million in 2025, holding a 30.3% share, and expected to grow at a CAGR of 4.2%, driven by regional digital health frameworks and oncology data integration.

Europe - Major Dominant Countries in the “Oncology Information System Market”

• Germany: Market size USD 211.6 million, share 27.0%, CAGR 4.3%, supported by strong clinical data infrastructure.
• United Kingdom: Market size USD 183.4 million, share 23.4%, CAGR 4.2%, driven by NHS digital oncology strategies.
• France: Market size USD 161.8 million, share 20.7%, CAGR 4.1%, due to national interoperability in cancer treatment data.
• Italy: Market size USD 124.5 million, share 15.9%, CAGR 4.1%, driven by oncology data integration systems.
• Spain: Market size USD 101.4 million, share 12.9%, CAGR 4.0%, fueled by hospital oncology digitization.

ASIA-PACIFIC

Asia-Pacific’s share was about 19 % of global OIS demand in recent years, but its growth momentum is high. Countries like China, India, Japan, Australia, South Korea, and Southeast Asian nations drive expansion. In 2024, approximately 28 % of new global OIS contracts were awarded in Asia-Pacific. Many new cancer hospitals in China and India include OIS in their initial infrastructure plans. For instance, ~35 Tier-1 Indian cancer centers tendered OIS systems in 2024. Adoption tends toward hosted/hybrid models—~60 % of APAC OIS deployments are cloud or hybrid to manage limited local IT overhead.

The Asia market is projected at USD 498.4 million in 2025, representing 19.3% share, and is forecasted to register a CAGR of 4.5%, fueled by expanding cancer care infrastructure and digital healthcare transformation.

Asia - Major Dominant Countries in the “Oncology Information System Market”

• China: Market size USD 194.7 million, share 39.1%, CAGR 4.6%, driven by oncology IT integration.
• Japan: Market size USD 142.8 million, share 28.7%, CAGR 4.4%, supported by smart oncology solutions.
• India: Market size USD 94.6 million, share 19.0%, CAGR 4.6%, fueled by hospital digitalization.
• South Korea: Market size USD 38.2 million, share 7.7%, CAGR 4.5%, led by precision oncology adoption.
• Singapore: Market size USD 28.1 million, share 5.6%, CAGR 4.4%, driven by research-driven oncology infrastructure.

MIDDLE EAST & AFRICA

MEA remains an emerging region in the Oncology Information System Market, accounting for ~10–12 % of global installations currently. Key early adopters include UAE, Saudi Arabia, South Africa, Egypt, and Nigeria. In the Gulf region, ~20 major cancer centers contracted OIS platforms in 2023-2025. Many Gulf region OIS systems are hybrid (on-premise + cloud fallback) due to concerns about connectivity and data sovereignty; ~56 % of MEA OIS deployments use such hybrid models. In Saudi Arabia and UAE, ~15 high-profile centers use full multi-module OIS suites today.

The Middle East and Africa market is valued at USD 167.9 million in 2025, accounting for a 6.5% share, with a CAGR of 4.3%, driven by government-led digital health initiatives and oncology care expansion.

Middle East and Africa - Major Dominant Countries in the “Oncology Information System Market”

• Saudi Arabia: Market size USD 62.3 million, share 37.1%, CAGR 4.4%, supported by national healthcare digitalization programs.
• UAE: Market size USD 38.5 million, share 22.9%, CAGR 4.3%, driven by integrated hospital IT systems.
• South Africa: Market size USD 29.4 million, share 17.5%, CAGR 4.2%, led by oncology care modernization.
• Qatar: Market size USD 22.1 million, share 13.2%, CAGR 4.3%, fueled by cancer center digital projects.
• Egypt: Market size USD 15.6 million, share 9.3%, CAGR 4.2%, supported by public hospital oncology expansion.

List of Top Oncology Information System Companies

• Accuray
• Flatiron Health
• Cerner
• Elekta
• Epic Systems Corporation
• Philips Healthcare
• Mckesson
• Varian Medical Systems
• RaySearch Laboratories

Cerner: holds approximately 13 % share in global OIS deployments

Elekta: accounts for roughly 12 % share in the oncology planning and information systems segment

Investment Analysis and Opportunities

Investment flows in the Oncology Information System Market continue to intensify. In 2023–2024, over 28 % of healthcare IT venture funding targeted oncology digital platforms, including OIS, AI modules, and imaging interop. At least 12 new funding rounds involved companies building oncology data platforms, some raising between USD 5 million and 20 million. Many strategic health tech investors now allocate ~8–10 % of digital health portfolios into oncology IT. Integration of AI, genomics, and imaging in OIS is fueling platform convergence, and ~30 % of OIS vendors redirect R&D budgets toward precision modules. In low- and middle-income countries, governments and development banks are offering matching funds—~20 infrastructure grants in 2024 supported OIS deployment in Africa and Southeast Asia.

New Product Development

The Oncology Information System Market is witnessing rapid innovation. In 2024, several vendors launched OIS modules with embedded AI for auto contouring, dosing suggestions, and toxicity prediction—these AI modules detect anomalies in >90 % of cases compared to manual baselines. One vendor released a cloud-native OIS module with zero client architecture, supporting 1,000+ concurrent users across multiple hospitals. A new OIS version launched in 2025 supports multi-omics integration, merging genomic, proteomic, and clinical data within a unified workflow—~25 % of pilot sites adopted this module. Another product increment added a mobile patient portal for remote symptom reporting, used by ~40 % of OIS clients in pilot phase.

Five Recent Developments

• In 2023, a leading OIS vendor secured a multi-centre contract to deploy integrated OIS suites across 25 U.K. cancer centers including compliance modules.
• In 2023, a major vendor partnered with a European radiotherapy manufacturer to embed planning modules in 100 new linear accelerators.
• In 2024, a U.S. academic cancer network launched a unified OIS across 8 hospitals, standardizing workflows and data sharing.
• In 2024, an OIS provider released an AI auto-segmentation upgrade deployed in 50 pilot institutes.
• In 2025, a Southeast Asian consortium implemented cloud-based OIS across 12 hospitals using remote patient monitoring modules in the rollout.

Report Coverage of Oncology Information System Market

The Oncology Information System Market Report covers holistic scope and depth for B2B decision makers. It spans solution segmentation (Patient Information Systems, Treatment Planning Systems, professional services) and application segmentation (medical, radiation, surgical oncology). The report also segments by end-user (hospitals, governmental institutions, research centers) across four major geographies — North America, Europe, Asia-Pacific, Middle East & Africa. Historical data covers 2018–2023, and projections extend to at least 2030, offering detailed deployment forecasts, share estimates, and demand drivers. The report includes 10+ leading OIS vendors with their market share positions, product portfolios, regional presence, and comparative matrices.

Oncology Information System Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2692.92 Million in 2026
Market Size Value By	USD 3933.58 Million by 2035
Growth Rate	CAGR of 4.3% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Patient Information Systems Treatment Planning Systems By Application : Hospitals Governmental Institutions Research Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample